Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Feb;62(2):377–383. doi: 10.1128/iai.62.2.377-383.1994

Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor.

Y Nakano 1, T Kasahara 1, N Mukaida 1, Y C Ko 1, M Nakano 1, K Matsushima 1
PMCID: PMC186118  PMID: 8300198

Abstract

Chemotactic factors regulate the recruitment of neutrophils, lymphocytes, or monocytes-macrophages to infectious and inflammatory sites. The purpose of this study was to determine whether monocyte-chemotactic and -activating factor (MCAF [MCP-1], a JE gene product) also influences the host defense mechanism against microbial infection. We evaluated the effect of recombinant human MCAF on the survival rate of mice systemically infected with Pseudomonas aeruginosa or Salmonella typhimurium. The administration of 2.5 micrograms of MCAF 6 h before infection completely protected the mice from lethal infection. Mice with cyclophosphamide-induced leukopenia exhibiting increased susceptibility to P. aeruginosa were also endowed with resistance by the same dose of MCAF. Administration of MCAF at -6 h was critical, since MCAF given either earlier or later than -6 h failed to rescue mice from lethal infection. The in vivo effect on the survival of mice paralleled the reduced recovery of viable P. aeruginosa or S. typhimurium from the peritoneal cavity, i.e., the number of recovered bacteria from the MCAF (2.5 micrograms per mouse)-treated mice was reduced to less than 2% of control mice for P. aeruginosa and 4% of control mice for S. typhimurium at 24 h. Since MCAF exhibited chemotaxis on murine macrophages as well as enhanced phagocytosis and killing of bacteria in vitro, the activation of macrophages, followed by the recruitment into the peritoneal cavity, is responsible for eliminating bacteria and thus enhancing the survival rate.

Full text

PDF
377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam R., Lett-Brown M. A., Forsythe P. A., Anderson-Walters D. J., Kenamore C., Kormos C., Grant J. A. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest. 1992 Mar;89(3):723–728. doi: 10.1172/JCI115648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bottazzi B., Walter S., Govoni D., Colotta F., Mantovani A. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J Immunol. 1992 Feb 15;148(4):1280–1285. [PubMed] [Google Scholar]
  3. Colotta F., Borré A., Wang J. M., Tattanelli M., Maddalena F., Polentarutti N., Peri G., Mantovani A. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol. 1992 Feb 1;148(3):760–765. [PubMed] [Google Scholar]
  4. Fischer-Stenger K., Marciano-Cabral F. The arginine-dependent cytolytic mechanism plays a role in destruction of Naegleria fowleri amoebae by activated macrophages. Infect Immun. 1992 Dec;60(12):5126–5131. doi: 10.1128/iai.60.12.5126-5131.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Furutani Y., Nomura H., Notake M., Oyamada Y., Fukui T., Yamada M., Larsen C. G., Oppenheim J. J., Matsushima K. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem Biophys Res Commun. 1989 Feb 28;159(1):249–255. doi: 10.1016/0006-291x(89)92430-3. [DOI] [PubMed] [Google Scholar]
  6. Graves D. T., Jiang Y. L., Williamson M. J., Valente A. J. Identification of monocyte chemotactic activity produced by malignant cells. Science. 1989 Sep 29;245(4925):1490–1493. doi: 10.1126/science.2781291. [DOI] [PubMed] [Google Scholar]
  7. Handa T., Mitsuyama M., Serushago B. A., Muramori K., Nomoto K. Co-operative effect of MCF and MAF(IFN-gamma) in the protection of mice against Listeria monocytogenes. Immunology. 1988 Nov;65(3):427–432. [PMC free article] [PubMed] [Google Scholar]
  8. Jiang Y., Beller D. I., Frendl G., Graves D. T. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 1992 Apr 15;148(8):2423–2428. [PubMed] [Google Scholar]
  9. Kasahara T., Mukaida N., Yamashita K., Yagisawa H., Akahoshi T., Matsushima K. IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology. 1991 Sep;74(1):60–67. [PMC free article] [PubMed] [Google Scholar]
  10. Kuna P., Reddigari S. R., Rucinski D., Oppenheim J. J., Kaplan A. P. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992 Feb 1;175(2):489–493. doi: 10.1084/jem.175.2.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kuna P., Reddigari S. R., Schall T. J., Rucinski D., Viksman M. Y., Kaplan A. P. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol. 1992 Jul 15;149(2):636–642. [PubMed] [Google Scholar]
  12. Lorsbach R. B., Russell S. W. A specific sequence of stimulation is required to induce synthesis of the antimicrobial molecule nitric oxide by mouse macrophages. Infect Immun. 1992 May;60(5):2133–2135. doi: 10.1128/iai.60.5.2133-2135.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Matsushima K., Larsen C. G., DuBois G. C., Oppenheim J. J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med. 1989 Apr 1;169(4):1485–1490. doi: 10.1084/jem.169.4.1485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McIntyre K. W., Unowsky J., DeLorenzo W., Benjamin W. Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1 alpha. Infect Immun. 1989 Jan;57(1):48–54. doi: 10.1128/iai.57.1.48-54.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Minami A., Fujimoto K., Ozaki Y., Nakamura S. Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha. Infect Immun. 1988 Dec;56(12):3116–3120. doi: 10.1128/iai.56.12.3116-3120.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nakano M., Onozuka K., Sakamoto K., Nakano Y., Shinomiya H., Saito-Taki T. Protective effect of cytokines in mice to Pseudomonas aeruginosa infection. Antibiot Chemother (1971) 1991;44:196–202. doi: 10.1159/000420314. [DOI] [PubMed] [Google Scholar]
  17. Nakano Y., Onozuka K., Terada Y., Shinomiya H., Nakano M. Protective effect of recombinant tumor necrosis factor-alpha in murine salmonellosis. J Immunol. 1990 Mar 1;144(5):1935–1941. [PubMed] [Google Scholar]
  18. Oppenheim J. J., Zachariae C. O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 1991;9:617–648. doi: 10.1146/annurev.iy.09.040191.003153. [DOI] [PubMed] [Google Scholar]
  19. Ozaki Y., Ohashi T., Minami A., Nakamura S. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a. Infect Immun. 1987 Jun;55(6):1436–1440. doi: 10.1128/iai.55.6.1436-1440.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rollins B. J., Sunday M. E. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol. 1991 Jun;11(6):3125–3131. doi: 10.1128/mcb.11.6.3125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rollins B. J., Walz A., Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood. 1991 Aug 15;78(4):1112–1116. [PubMed] [Google Scholar]
  22. Schall T. J., Bacon K., Toy K. J., Goeddel D. V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990 Oct 18;347(6294):669–671. doi: 10.1038/347669a0. [DOI] [PubMed] [Google Scholar]
  23. Singh R. K., Berry K., Matsushima K., Yasumoto K., Fidler I. J. Synergism between human monocyte chemotactic and activating factor and bacterial products for activation of tumoricidal properties in murine macrophages. J Immunol. 1993 Sep 1;151(5):2786–2793. [PubMed] [Google Scholar]
  24. Yoshida T., Cohen S. Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity. J Immunol. 1974 Apr;112(4):1540–1547. [PubMed] [Google Scholar]
  25. Yoshimura T., Leonard E. J. Secretion by human fibroblasts of monocyte chemoattractant protein-1, the product of gene JE. J Immunol. 1990 Mar 15;144(6):2377–2383. [PubMed] [Google Scholar]
  26. Yoshimura T., Robinson E. A., Tanaka S., Appella E., Kuratsu J., Leonard E. J. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med. 1989 Apr 1;169(4):1449–1459. doi: 10.1084/jem.169.4.1449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yoshimura T., Yuhki N., Moore S. K., Appella E., Lerman M. I., Leonard E. J. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 1989 Feb 27;244(2):487–493. doi: 10.1016/0014-5793(89)80590-3. [DOI] [PubMed] [Google Scholar]
  28. Zachariae C. O., Anderson A. O., Thompson H. L., Appella E., Mantovani A., Oppenheim J. J., Matsushima K. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med. 1990 Jun 1;171(6):2177–2182. doi: 10.1084/jem.171.6.2177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van der Meer J. W., Barza M., Wolff S. M., Dinarello C. A. A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1620–1623. doi: 10.1073/pnas.85.5.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES